$5521 | SAVE $974 | Single User
$11042 | SAVE $1,948 | Site License
$14446 | SAVE $2,549 | Enterprise License

MediPoint: Women’s Health - Global Analysis and Market Forecasts

MediPoint: Women’s Health - Global Analysis and Market Forecasts
[Lowest Price Guaranteed: $5,521]

Published by Global Data: 01 Nov 2015 | 17752 | In Stock

Introduction

MediPoint: Women’s Health - Global Analysis and Market Forecasts

Summary

The women’s health medical devices market encompasses treatments for conditions that are particular to the adult female anatomy. This includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, as well as pelvic disorders such as female stress urinary incontinence. Moreover, there is a sub-segment of the female population that no longer desire to become pregnant, and seek permanent solutions to avoid conception.

In recent years, minimally invasive techniques and technologies have been developed to treat these conditions as alternatives to conventional surgery; these technologies are expected to see increased adoption in the coming years due to increased physician and patient awareness as well as an increasing number of women who are proactively seeking treatment for these embarrassing, and sometimes debilitating, conditions. However, recent lawsuits related to safety issues with some of these devices that are receiving widespread media attention, particularly in the urinary incontinence sling market, have caused some women to be skeptical of these newer technologies.

The technologies covered in this report include global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. This report focuses on the global women’s health market in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of women’s health devices.

Highlights

Key Questions Answered

- What is the current and future women’s health market outlook in the developed and emerging markets? What trends are affecting the global market?

- Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

- What are the unmet needs with women’s health devices currently on the market? How will emerging technologies fulfill these unmet needs?

- What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for women’s health devices?

- What are the challenges that have hindered widespread adoption of newer technologies?

- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global women’s health market?

Scope

- Overview of women’s health, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.

- Annualized total women’s health market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks by country through 2021.

- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.

- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

- Analysis of the current and future market competition in the global women’s health market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents
for MediPoint: Women’s Health - Global Analysis and Market Forecasts

  • 1 Table of Contents

    1 Table of Contents 6

    1.1 List of Tables 12

    1.2 List of Figures 21

    2 Introduction 28

    2.1 Catalyst 29

    2.2 Related Reports 29

    3 Industry Overview 30

    3.1 Overview 30

    3.1.1 Anatomy 30

    3.2 Indications 31

    3.2.1 Overview 31

    3.2.2 Abnormal Uterine Conditions 31

    3.2.3 Female Urinary Incontinence 32

    3.3 Clinical Presentation 33

    3.3.1 Abnormal Uterine Conditions 33

    3.3.2 Female Urinary Incontinence 36

    3.4 Market Segmentation 38

    3.5 Market Access 40

    3.5.1 Purchasing Decisions 40

    3.6 Influence of Clinical Trials 40

    3.7 Adoption 40

    3.8 Regulation 41

    3.8.1 US 41

    3.8.2 5EU 42

    3.8.3 Asia-Pacific 43

    3.8.4 South America 46

    3.9 Reimbursement 47

    3.9.1 US 47

    3.9.2 5EU 50

    3.9.3 Asia-Pacific 54

    3.9.4 South America 56

    3.10 Procedure Trends 57

    3.10.1 Global Overview 57

    3.10.2 By Region 58

    3.11 Regulatory Issues/Recalls 74

    3.11.1 Hologic Discontinues Manufacturing, Marketing, and Sales of Adiana 74

    3.11.2 Recall of Numerous Transvaginal Mesh Products 75

    3.12 M&As, Key Partnerships 75

    3.12.1 Bayer Health Acquires Conceptus for .1 Billion 75

    3.12.2 Boston Scientific Acquires IoGyn for m 75

    3.13 Economic Impact 76

    3.13.1 Indirect Costs 76

    3.13.2 Direct Costs 76

    4 Unmet Needs 78

    4.1 Overview 78

    4.2 Endometrial Ablation/Resection Devices 78

    4.2.1 Better Fluid Management 78

    4.2.2 Improved Imaging Guidance 79

    4.2.3 Regulating Depth of Ablation 79

    4.3 Uterine Fibroid Embolization Agents 80

    4.3.1 Addressing Fibroid Recurrence 80

    4.3.2 Assessing Effect on Fertility 80

    4.3.3 Preventing Ovarian Failure 81

    4.4 Female Sterilization Devices 81

    4.4.1 Accelerated Scar Tissue Formation 81

    4.4.2 Lack of Reversibility 82

    4.4.3 Preventing Micro-insert Migration 83

    4.4.4 Preventing Perforation 83

    4.4.5 Trocar Size Reduction 84

    4.5 Female Urinary Incontinence Slings 84

    4.5.1 Anatomical Adaptation 84

    4.5.2 Single-Incision Slings 85

    5 Market Opportunity Analysis 86

    5.1 Overview 86

    5.2 Endometrial Ablation/Resection Devices 86

    5.2.1 Targeted Fibroid Ablation 86

    5.3 Uterine Fibroid Embolization Agents 87

    5.3.1 Novel Agents 87

    5.4 Female Sterilization Devices 88

    5.4.1 Raising Patient Awareness 88

    5.4.2 Rapid Transcervical Sterilization 88

    5.5 Female Urinary Incontinence Slings 89

    5.5.1 Materials and Coatings 89

    5.5.2 European and APAC Markets 89

    6 Market Drivers and Barriers 91

    6.1 Endometrial Ablation/Resection 91

    6.1.1 Driver: Patient Preference for Minimally Invasive Treatments 91

    6.1.2 Driver: Growing Procedure Volume 91

    6.1.3 Barrier: High Device and Procedure Cost 92

    6.1.4 Substitute: Hysterectomy 92

    6.1.5 Substitute: Intrauterine Devices 93

    6.2 Uterine Fibroid Embolization Agents 94

    6.2.1 Driver: Increasing Prevalence of Uterine Fibroids 94

    6.2.2 Driver: Improving Imaging Capabilities 94

    6.2.3 Barrier: Lack of Patient Awareness 94

    6.2.4 Substitute: MRI-guided Focused Ultrasound 95

    6.2.5 Substitute: Myomectomy 95

    6.3 Female Sterilization Devices 96

    6.3.1 Driver: Growing Female Population using Modern Contraception 96

    6.3.2 Driver: Increasing Adoption of Transcervical Sterilization 96

    6.3.3 Barrier: Patient Preference for Reversible Contraception 96

    6.3.4 Substitute: Traditional Contraception 97

    6.4 Female Urinary Incontinence Slings 97

    6.4.1 Driver: Growing Treatment Rates and Use of Surgery 97

    6.4.2 Barrier: Highly Litigious US Market 98

    6.4.3 Substitute: Surgical Repair 98

    6.4.4 Substitute: Pelvic Floor Electrical Stimulation 99

    7 Competitive Assessment 100

    7.1 Overview 100

    7.2 Classification Based on Features 101

    7.2.1 Endometrial Ablation Devices 101

    7.2.2 Endometrial Resection Devices 102

    7.2.3 Uterine Fibroid Embolization Agents 103

    7.2.4 Female Sterilization Devices 104

    7.2.5 Female Urinary Incontinence Slings 105

    7.3 Key Product Profiles 106

    7.3.1 Endometrial Ablation Devices 106

    7.3.2 Endometrial Resection Devices 119

    7.3.3 Uterine Fibroid Embolization Agents 126

    7.3.4 Female Sterilization Devices 132

    7.3.5 Female Urinary Incontinence Slings 134

    8 Pipeline Assessment 141

    8.1 Overview 141

    8.2 Key Product Profiles 141

    8.2.1 Endometrial Ablation Devices 141

    8.2.2 Uterine Fibroid Embolization Agents 143

    8.2.3 Female Sterilization Devices 144

    8.2.4 Female Urinary Incontinence Slings 145

    9 Clinical Trials to Watch 148

    9.1 Overview 148

    9.2 Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation 148

    9.3 Post Market Study of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 149

    9.4 Safety & Effectiveness Study of Aegea Vapor System to Treat Excessive Uterine Bleeding 149

    9.5 The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 149

    10 Current and Future Players 151

    10.1 Overview 151

    10.2 Trends in Corporate Strategy 151

    10.3 Company Profiles 151

    10.3.1 American Medical Systems 151

    10.3.2 AngioDynamics 152

    10.3.3 Bayer Healthcare (Bayer AG) 154

    10.3.4 Boston Scientific 156

    10.3.5 BTG 157

    10.3.6 Coloplast 159

    10.3.7 Cook Medical 160

    10.3.8 CooperSurgical 161

    10.3.9 C.R. Bard 163

    10.3.10 Ethicon (Johnson & Johnson) 164

    10.3.11 Femcare-Nikomed (Utah Medical Products) 166

    10.3.12 Hologic 167

    10.3.13 Karl Storz 168

    10.3.14 Olympus 169

    10.3.15 Richard Wolf 171

    10.3.16 Stryker 172

    11 Market Outlook 174

    11.1 Company Market Share 174

    11.1.1 Global Overview 174

    11.1.2 By Segment 174

    11.2 By Market Segment 182

    11.2.1 Global Overview 182

    11.2.2 By Segment 184

    11.3 By Geography 199

    11.3.1 Global Overview 199

    11.3.2 By Region 202

    11.3.3 By Country 208

    12 Appendix 321

    12.1 Bibliography 321

    12.2 Abbreviations 337

    12.3 Report Methodology 341

    12.3.1 Overview 341

    12.3.2 Coverage 341

    12.3.3 Secondary Research 341

    12.4 Forecasting Methodology 343

    12.5 Physicians and Specialists Included in This Study 344

    12.6 Primary Research - Prescriber Survey 346

    12.7 About the Authors 347

    12.7.1 Analysts 347

    12.7.2 Global Head of Medical Devices 348

    12.8 About GlobalData 349

    12.9 Disclaimer 349

List Of Tables
in MediPoint: Women’s Health - Global Analysis and Market Forecasts

1.1 List of Tables

Table 1: Types of Uterine Fibroids 32

Table 2: Types of Female Urinary Incontinence 32

Table 3: Drug and Hormone Treatments for Menorrhagia 34

Table 4: Surgical Treatments for Menorrhagia 35

Table 5: Treatments for Stress, Urge, and Mixed Urinary Incontinence 37

Table 6: Market Segmentation for Women’s Health Market 39

Table 7: FDA Medical Device Classification System 41

Table 8: Regulatory Differences Between the US and EU for the Approval of Medical Devices 42

Table 9: CPT Codes and Description of Coverage for Gynecological Procedures 48

Table 10: APC Codes and Description of Coverage for Gynecological Procedures 48

Table 11: ICD-10 Codes Associated with Causes of Menorrhagia and Uterine Fibroids 49

Table 12: CPT Codes and Description of Coverage for Urinary Incontinence Sling Procedures 49

Table 13: APC Codes and Description of Coverage for Urinary Incontinence Sling Procedures 49

Table 14: ICD-10 Codes Associated with Female Stress Urinary Incontinence 50

Table 15: Endometrial Ablation Devices, SWOT Analysis, 2015 101

Table 16: Currently Marketed Endometrial Ablation Devices, 2015 102

Table 17: Endometrial Resection, SWOT Analysis, 2015 102

Table 18: Uterine Fibroid Embolization, SWOT Analysis, 2015 104

Table 19: Device-based Permanent Female Sterilization, SWOT Analysis, 2015 105

Table 20: Currently Marketed Notable Female Urinary Incontinence Slings, 2015 106

Table 21: Female Urinary Incontinence Slings, SWOT Analysis, 2015 106

Table 22: Product Profile - Cavaterm (Veldana Medical) 107

Table 23: Cavaterm, SWOT Analysis, 2015 108

Table 24: Product Profile - ThermaChoice (Ethicon) 109

Table 25: ThermaChoice, SWOT Analysis, 2015 109

Table 26: Product Profile - Genesys HTA (Boston Scientific) 110

Table 27: Genesys HTA, SWOT Analysis, 2015 111

Table 28: Product Profile - NovaSure (Hologic) 112

Table 29: NovaSure, SWOT Analysis, 2015 112

Table 30: Product Profile - Minerva Endometrial Ablation System (Minerva Surgical) 113

Table 31: Minerva Endometrial Ablation System, SWOT Analysis, 2015 114

Table 32: Product Profile - Her Option (CooperSurgical) 114

Table 33: Her Option, SWOT Analysis, 2015 115

Table 34: Product Profile - Acculis MTA (AngioDynamics) 116

Table 35: Acculis MTA, SWOT Analysis, 2015 117

Table 36: Product Profile - Acessa (Halt Medical) 117

Table 37: Acessa, SWOT Analysis, 2015 118

Table 38: Product Profile - Sonata (Gynesonics) 119

Table 39: Sonata, SWOT Analysis, 2015 119

Table 40: Product Profile - 26Fr Continuous Flow Resectoscope (Stryker) 120

Table 41: 26Fr Continuous Flow Resectoscope, SWOT Analysis, 2015 120

Table 42: Product Profile - Karl Storz Bipolar Resectoscope (Karl Storz) 121

Table 43: Karl Storz Bipolar Resectoscope, SWOT Analysis, 2015 122

Table 44: Product Profile - SurgMaster Resectoscope (Olympus) 123

Table 45: SurgMaster Resectoscope, SWOT Analysis, 2015 123

Table 46: Product Profile - Princess Resectoscope (Richard Wolf) 124

Table 47: Princess Resectoscope, SWOT Analysis, 2015 124

Table 48: Product Profile - Versapoint (Ethicon) 125

Table 49: Versapoint, SWOT Analysis, 2015 126

Table 50: Product Profile - Gelfoam (Pfizer) 126

Table 51: Gelfoam, SWOT Analysis, 2015 127

Table 52: Product Profile - Bead Block (BTG) 127

Table 53: Bead Block, SWOT Analysis, 2015 128

Table 54: Product Profile - Contour PVA Embolization Particles (Boston Scientific) 129

Table 55: Contour PVA Embolization Particles, SWOT Analysis, 2015 129

Table 56: Product Profile - PVA Foam Embolization Particles (Cook Medical) 130

Table 57: PVA Foam Embolization Particles, SWOT Analysis, 2015 130

Table 58: Product Profile - Embosphere Microspheres (Merit Medical Systems) 131

Table 59: Embosphere Microspheres, SWOT Analysis, 2015 132

Table 60: Product Profile - Filshie Clip (Femcare-Nikomed) 132

Table 61: Filshie Clip, SWOT Analysis, 2015 133

Table 62: Product Profile - Essure (Bayer Healthcare) 134

Table 63: Essure, SWOT Analysis, 2015 134

Table 64: Product Profile - Align Urethral Support System (C.R. Bard) 135

Table 65: Align Urethral Support System, SWOT Analysis, 2015 135

Table 66: Product Profile - Altis Single Incision Sling (Coloplast) 136

Table 67: Altis Single Incision Sling, SWOT Analysis, 2015 137

Table 68: Product Profile - Gynecare TVT (Ethicon) 137

Table 69: Gynecare TVT, SWOT Analysis, 2015 138

Table 70: Product Profile - MiniArc Single-Incision Sling (American Medical Systems) 139

Table 71: MiniArc Single-Incision Sling, SWOT Analysis, 2015 139

Table 72: Product Profile - Solyx (Boston Scientific) 140

Table 73: Solyx, SWOT Analysis, 2015 140

Table 74: Product Profile - Aegea Vapor System (Aegea Medical) 142

Table 75: Aegea Vapor System, SWOT Analysis, 2015 142

Table 76: Product Profile - Cryothermic Therapy (Channel Medsystems) 143

Table 77: Cryothermic Therapy, SWOT Analysis, 2015 143

Table 78: Product Profile - Biodegradable Bead 144

Table 79: Biodegradable Bead, SWOT Analysis, 2015 144

Table 80: Product Profile - FemBloc 145

Table 81: FemBloc, SWOT Analysis, 2015 145

Table 82: Product Profile - PTMC Mesh 146

Table 83: PTMC Mesh, SWOT Analysis, 2015 146

Table 84: Product Profile - sensiTVT 147

Table 85: sensiTVT, SWOT Analysis, 2015 147

Table 86: Company Profile - American Medical Systems 152

Table 87: American Medical Systems, SWOT Analysis, 2015 152

Table 88: Company Profile - AngioDynamics 153

Table 89: AngioDynamics, SWOT Analysis, 2015 154

Table 90: Company Profile - Bayer Healthcare 155

Table 91: Bayer Healthcare, SWOT Analysis, 2015 155

Table 92: Company Profile - Boston Scientific 156

Table 93: Boston Scientific, SWOT Analysis, 2015 157

Table 94: Company Profile - BTG 158

Table 95: BTG, SWOT Analysis, 2015 158

Table 96: Company Profile - Coloplast 159

Table 97: Coloplast, SWOT Analysis, 2015 160

Table 98: Company Profile - Cook Medical 160

Table 99: Cook Medical, SWOT Analysis, 2015 161

Table 100: Company Profile - CooperSurgical 162

Table 101: CooperSurgical, SWOT Analysis, 2015 162

Table 102: Company Profile - C.R. Bard 163

Table 103: C.R. Bard, SWOT Analysis, 2015 164

Table 104: Company Profile - Ethicon 165

Table 105: Ethicon, SWOT Analysis, 2015 165

Table 106: Company Profile - Femcare-Nikomed 166

Table 107: Femcare-Nikomed, SWOT Analysis, 2015 167

Table 108: Company Profile - Hologic 167

Table 109: Hologic, SWOT Analysis, 2015 168

Table 110: Company Profile - Karl Storz 169

Table 111: Karl Storz, SWOT Analysis, 2015 169

Table 112: Company Profile - Olympus 170

Table 113: Olympus, SWOT Analysis, 2015 170

Table 114: Company Profile - Richard Wolf 171

Table 115: Richard Wolf, SWOT Analysis, 2015 172

Table 116: Company Profile - Stryker 172

Table 117: Stryker, SWOT Analysis, 2015 173

Table 118: Global Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 183

Table 119: Global Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 185

Table 120: Global Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 190

Table 121: Global Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 192

Table 122: Global Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 195

Table 123: Global Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 198

Table 124: Global Women’s Health Market Forecast ($m) by Country, 2011-2021 201

Table 125: 5EU Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 204

Table 126: APAC Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 207

Table 127: US Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 210

Table 128: US Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 212

Table 129: US Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 215

Table 130: US Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 216

Table 131: US Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 218

Table 132: US Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 220

Table 133: France Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 221

Table 134: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 223

Table 135: France Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 226

Table 136: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 227

Table 137: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 229

Table 138: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 231

Table 139: Germany Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 232

Table 140: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 234

Table 141: Germany Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 237

Table 142: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 238

Table 143: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 240

Table 144: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 242

Table 145: Italy Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 244

Table 146: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 246

Table 147: Italy Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 249

Table 148: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 250

Table 149: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 252

Table 150: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 253

Table 151: Spain Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 255

Table 152: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 258

Table 153: Spain Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 260

Table 154: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 261

Table 155: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 263

Table 156: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 265

Table 157: UK Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 266

Table 158: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 268

Table 159: UK Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 271

Table 160: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 272

Table 161: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 275

Table 162: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 276

Table 163: Japan Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 278

Table 164: Japan Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 281

Table 165: Japan Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 282

Table 166: Japan Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 283

Table 167: Japan Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 285

Table 168: Japan Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 287

Table 169: China Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 288

Table 170: China Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 290

Table 171: China Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 293

Table 172: China Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 294

Table 173: China Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 296

Table 174: China Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 298

Table 175: India Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 299

Table 176: India Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 301

Table 177: India Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 304

Table 178: India Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 305

Table 179: India Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 307

Table 180: India Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 309

Table 181: Brazil Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 310

Table 182: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 312

Table 183: Brazil Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 315

Table 184: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 316

Table 185: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 318

Table 186: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 320

List Of Figures, Charts and Diagrams
in MediPoint: Women’s Health - Global Analysis and Market Forecasts

1.2 List of Figures

Figure 1: Percentage Breakdown of Urinary Incontinence, by Type 33

Figure 2: Percentage of Patients with Menorrhagia Receiving Treatment, by Type 36

Figure 3: Percentage of Patients with Urinary Incontinence Receiving Treatment, by Type 38

Figure 4: US Procedure Volume Forecast, Endometrial Resection, 2011-2021 58

Figure 5: US Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 60

Figure 6: US Procedure Volume Forecast, Female Sterilization, 2011-2021 61

Figure 7: US Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 62

Figure 8: 5EU Procedure Volume Forecast, Endometrial Resection, 2011-2021 63

Figure 9: 5EU Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 64

Figure 10: 5EU Procedure Volume Forecast, Female Sterilization, 2011-2021 65

Figure 11: 5EU Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 66

Figure 12: APAC Procedure Volume Forecast, Endometrial Resection, 2011-2021 67

Figure 13: APAC Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 68

Figure 14: APAC Procedure Volume Forecast, Female Sterilization, 2011-2021 69

Figure 15: APAC Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 70

Figure 16: Brazil Procedure Volume Forecast, Endometrial Resection, 2011-2021 71

Figure 17: Brazil Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 72

Figure 18: Brazil Procedure Volume Forecast, Female Sterilization, 2011-2021 73

Figure 19: Brazil Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 74

Figure 20: Global Company Market Shares for Endometrial Ablation, 2014 175

Figure 21: Global Company Market Shares for Endometrial Resection, 2014 176

Figure 22: Global Company Market Shares for Uterine Fibroid Embolization Agents, 2014 178

Figure 23: Global Company Market Shares for Female Sterilization Devices 2014 179

Figure 24: Global Company Market Shares for Female Urinary Incontinence Slings, 2014 180

Figure 25: 5EU Company Market Shares for Female Urinary Incontinence Slings, 2014 181

Figure 26: APAC Company Market Shares for Female Urinary Incontinence Slings, 2014 182

Figure 27: Global Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 183

Figure 28: Global Women’s Health Market Share by Market Segment, 2014 and 2021 184

Figure 29: Global Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 185

Figure 30: Global Endometrial Ablation Market Share by Market Segment, 2014 and 2021 188

Figure 31: Global Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 189

Figure 32: Global TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 189

Figure 33: Global Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 192

Figure 34: Global Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 194

Figure 35: Global Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 195

Figure 36: Global Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 197

Figure 37: Global Female Urinary Incontinence Slings Market Forecast ($m) by Market Segment, 2011-2021 198

Figure 38: Global Women’s Health Market Forecast ($m) by Country, 2011-2021 200

Figure 39: Global Women’s Health Market Share by Country, 2014 and 2021 202

Figure 40: 5EU Women’s Health Market Forecast ($m) by Segment, 2011-2021 203

Figure 41: 5EU Women’s Health Market Share by Market Segment, 2014 and 2021 205

Figure 42: APAC Women’s Health Market Forecast ($m) by Segment, 2011-2021 206

Figure 43: APAC Women’s Health Market Share by Market Segment, 2014 and 2021 208

Figure 44: US Women’s Health Market Forecast ($m) by Segment, 2011-2021 209

Figure 45: US Women’s Health Market Share by Market Segment, 2014 and 2021 211

Figure 46: US Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 212

Figure 47: US Endometrial Ablation Market Share by Market Segment, 2014 and 2021 213

Figure 48: US Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 214

Figure 49: US TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 214

Figure 50: US Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 216

Figure 51: US Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 217

Figure 52: US Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 218

Figure 53: US Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 219

Figure 54: US Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 220

Figure 55: France Women’s Health Market Forecast ($m) by Segment, 2011-2021 221

Figure 56: France Women’s Health Market Share by Market Segment, 2014 and 2021 222

Figure 57: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 223

Figure 58: France Endometrial Ablation Market Share by Market Segment, 2014 and 2021 224

Figure 59: France Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 225

Figure 60: France TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 225

Figure 61: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 227

Figure 62: France Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 228

Figure 63: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 229

Figure 64: France Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 230

Figure 65: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 231

Figure 66: Germany Women’s Health Market Forecast ($m) by Segment, 2011-2021 232

Figure 67: Germany Women’s Health Market Share by Market Segment, 2014 and 2021 233

Figure 68: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 234

Figure 69: Germany Endometrial Ablation Market Share by Market Segment, 2014 and 2021 235

Figure 70: Germany Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 236

Figure 71: Germany TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 236

Figure 72: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 238

Figure 73: Germany Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 239

Figure 74: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 240

Figure 75: Germany Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 241

Figure 76: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 242

Figure 77: Italy Women’s Health Market Forecast ($m) by Segment, 2011-2021 243

Figure 78: Italy Women’s Health Market Share by Market Segment, 2014 and 2021 245

Figure 79: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 246

Figure 80: Italy Endometrial Ablation Market Share by Market Segment, 2014 and 2021 247

Figure 81: Italy Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 248

Figure 82: Italy TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 248

Figure 83: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 250

Figure 84: Italy Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 251

Figure 85: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 252

Figure 86: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 253

Figure 87: Spain Women’s Health Market Forecast ($m) by Segment, 2011-2021 254

Figure 88: Spain Women’s Health Market Share by Market Segment, 2014 and 2021 256

Figure 89: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 257

Figure 90: Spain Endometrial Ablation Market Share by Market Segment, 2014 and 2021 258

Figure 91: Spain Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 259

Figure 92: Spain TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 260

Figure 93: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 261

Figure 94: Spain Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 262

Figure 95: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 263

Figure 96: Spain Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 264

Figure 97: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 265

Figure 98: UK Women’s Health Market Forecast ($m) by Segment, 2011-2021 266

Figure 99: UK Women’s Health Market Share by Market Segment, 2014 and 2021 267

Figure 100: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 268

Figure 101: UK Endometrial Ablation Market Share by Market Segment, 2014 and 2021 269

Figure 102: UK Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 270

Figure 103: UK TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 270

Figure 104: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 272

Figure 105: UK Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 273

Figure 106: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 274

Figure 107: UK Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 275

Figure 108: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 276

Figure 109: Japan Women’s Health Market Forecast ($m) by Segment, 2011-2021 277

Figure 110: Japan Women’s Health Market Share by Market Segment, 2014 and 2021 279

Figure 111: Japan Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 280

Figure 112: Japan Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 281

Figure 113: Japan TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 282

Figure 114: Japan Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 283

Figure 115: Japan Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 284

Figure 116: Japan Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 285

Figure 117: Japan Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 286

Figure 118: Japan Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 287

Figure 119: China Women’s Health Market Forecast ($m) by Segment, 2011-2021 288

Figure 120: China Women’s Health Market Share by Market Segment, 2014 and 2021 289

Figure 121: China Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 290

Figure 122: China Endometrial Ablation Market Share by Market Segment, 2014 and 2021 291

Figure 123: China Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 292

Figure 124: China TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 292

Figure 125: China Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 294

Figure 126: China Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 295

Figure 127: China Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 296

Figure 128: China Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 297

Figure 129: China Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 298

Figure 130: India Women’s Health Market Forecast ($m) by Segment, 2011-2021 299

Figure 131: India Women’s Health Market Share by Market Segment, 2014 and 2021 300

Figure 132: India Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 301

Figure 133: India Endometrial Ablation Market Share by Market Segment, 2014 and 2021 302

Figure 134: India Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 303

Figure 135: India TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 303

Figure 136: India Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 305

Figure 137: India Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 306

Figure 138: India Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 307

Figure 139: India Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 308

Figure 140: India Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 309

Figure 141: Brazil Women’s Health Market Forecast ($m) by Segment, 2011-2021 310

Figure 142: Brazil Women’s Health Market Share by Market Segment, 2014 and 2021 311

Figure 143: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 312

Figure 144: Brazil Endometrial Ablation Market Share by Market Segment, 2014 and 2021 313

Figure 145: Brazil Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 314

Figure 146: Brazil TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 314

Figure 147: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 316

Figure 148: Brazil Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 317

Figure 149: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 318

Figure 150: Brazil Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 319

Figure 151: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 320

Figure 152: Primary Research Participants, by Country 346

Additional Details

Publisher

Global Data

Publisher Information

Reference

17752 | GDME0218MAR

Number of Pages

350

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! MediPoint: Renal Dialysis Equipment - Global Analysis and Market Forecasts
MediPoint: Renal Dialysis Equipment - Global Analysis and Market ForecastsSummaryRenal dialysis equi...
04 May 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Contrast Media Injectors - Global Analysis and Market Forecasts
MediPoint: Contrast Media Injectors - Global Analysis and Market ForecastsSummaryContrast media inje...
01 May 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Biopsy Devices - Global Analysis and Market Forecasts
MediPoint: Biopsy Devices - Global Analysis and Market ForecastsSummaryCancer is the uncontrolled gr...
01 Apr 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Renal Denervation - Global Analysis and Market Forecasts
MediPoint: Renal Denervation - Global Analysis and Market ForecastsSummaryRenal denervation catheter...
01 Apr 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Contrast Media - Global Analysis and Market Forecasts
MediPoint: Contrast Media - Global Analysis and Market ForecastsSummaryContrast media are a group of...
01 Apr 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts
MediPoint: Peripheral Vascular Interventions - Global Analysis and Market ForecastsSummaryThe periph...
14 Mar 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
MediPoint: Point of Care Diagnostics - Global Analysis and Market ForecastsSummaryPoint-of-care test...
01 Mar 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Electrosurgical Devices - Global Analysis and Market Forecasts
MediPoint: Electrosurgical Devices - Global Analysis and Market ForecastsSummaryElectrosurgical gene...
01 Mar 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Endoscopy - Global Analysis and Market Forecasts
MediPoint: Endoscopy - Global Analysis and Market ForecastsSummaryThe global endoscopy market is a d...
01 Nov 2015 by Global Data USD $5,521 (normally
USD $6,495)
More Info
SAVE 15% today! MediPoint: Compression Therapy - Global Analysis and Market Forecasts
MediPoint: Compression Therapy - Global Analysis and Market ForecastsSummaryCompression therapy prod...
01 Oct 2015 by Global Data USD $5,521 (normally
USD $6,495)
More Info

This report is published by Global Data

Download Free Report Summary PDF

MediPoint: Women’s Health - Global Analysis and Market Forecasts | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...